Papers by Jires Tunguhole
German Health Practice Collection (2017), Jul 28, 2017
or by visiting the Collection's homepage (health. bmz.de/ghpc) where all case studies, as well as... more or by visiting the Collection's homepage (health. bmz.de/ghpc) where all case studies, as well as related materials, are available for download. Front cover photo: Worker in a pharmaceutical manufacturing site. GERMAN HEALTH PRACTICE COLLECTION Working together to generate and share knowledge The German Health Practice Collection (GHPC) is a joint initiative of the German Federal Ministry for Economic Cooperation and Development (BMZ) and its implementing agencies, the Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) GmbH and KfW Development Bank (KfW). Established in 2004, the Collection is built around a series of case studies which identify and document insights generated during the implementation of German-supported health and social protection programmes. Since 2017, it also includes evidence briefs which synthesise current knowledge about specific questions of relevance to German development cooperation in the areas of health and social protection. Case studies: A collaborative approach to learning from implementation The GHPC case studies identify, document and share knowledge generated in the course of implementing German-supported development interventions. In an annual call for proposals, GIZ and KfW staff from around the world submit proposals of implementation experiences they consider worthy of documentation. The proposals are commented upon and ranked by GIZ-and KfW peers to ensure that they reflect issues of broader technical and political relevance. Guided by their assessment, BMZ decides which proposals should be developed into case studies. A GHPC researcher/writer assigned to develop the case study reviews available documentation and visits the programme site to get first-hand impressions of implementation and to interview programme staff, partners, beneficiaries and other stakeholders. In an ongoing critical and reflective exchange with the staff of the German-supported programme and their partner institutions, he or she analyses and documents how they approached a specific development challenge, how they dealt with difficulties and adapted their approaches accordingly, and what they learned in this process about effective implementation. Prior to publication, independent peer reviewers who are international experts in their fields review the case studies and assess whether the documented insights are worth sharing with an international audience. A summary of their reviews is included at the end of each case study. Evidence briefs: Research syntheses to guide policy and programming The Collection also includes evidence briefs which summarise the current state of knowledge on specific development-related questions, including areas of emerging interest for German development cooperation. Each brief's concept and guiding questions are developed in consultation with BMZ and with GIZ and/or KfW colleagues working in the given topic area. An independent researcher or team of researchers develops the evidence brief on the basis of literature reviews, interviews and data analysis, including a review of German-supported programming in the field. The evidence briefs are intended to contribute to international debates and to inform decision-making about development interventions and programmes.
Health Policy and Planning, 2018
The benefits of local production of pharmaceuticals in Africa for local access to medicines and t... more The benefits of local production of pharmaceuticals in Africa for local access to medicines and to effective treatment remain contested. There is scepticism among health systems experts internationally that production of pharmaceuticals in sub-Saharan Africa (SSA) can provide competitive prices, quality and reliability of supply. Meanwhile low-income African populations continue to suffer poor access to a broad range of medicines, despite major international funding efforts. A current wave of pharmaceutical industry investment in SSA is associated with active African government promotion of pharmaceuticals as a key sector in industrialization strategies. We present evidence from interviews in 2013-15 and 2017 in East Africa that health system actors perceive these investments in local production as an opportunity to improve access to medicines and supplies. We then identify key policies that can ensure that local health systems benefit from the investments. We argue for a 'local health' policy perspective, framed by concepts of proximity and positionality, which works with local priorities and distinct policy time scales and identifies scope for incentive alignment to generate mutually beneficial health-industry linkages and strengthening of both sectors. We argue that this local health perspective represents a distinctive shift in policy framing: it is not necessarily in conflict with 'global health' frameworks but poses a challenge to some of its underlying assumptions.
Industrial development in pharmaceuticals in Africa can support health system strengthening Devel... more Industrial development in pharmaceuticals in Africa can support health system strengthening Developing local pharmaceutical production can improve access to medicines and help to generate the scientific, technological and skills base for building stronger and more resilient health systems. These health-industry mutual benefits also depend on funding and managing competent, inclusive, population-focused health services, and on effective industrial regulation for quality assurance. Local and global perspectives on emergency preparedness differ: both must be addressed Global health security frameworks focus on technologies for emergencies that threaten the wider world. African experts shift the focus onto breaking supply constraints for recurrent lethal emergencies by building local supply capacities and organisational expertise. Both contributions are needed to build medium-term health security. External actors can support an upward spiral of health-industry synergies An upward spiral...
WIDER Working Paper
provides economic analysis and policy advice with the aim of promoting sustainable and equitable ... more provides economic analysis and policy advice with the aim of promoting sustainable and equitable development. The Institute began operations in 1985 in Helsinki, Finland, as the first research and training centre of the United Nations University. Today it is a unique blend of think tank, research institute, and UN agency-providing a range of services from policy advice to governments as well as freely available original research. The Institute is funded through income from an endowment fund with additional contributions to its work programme from Finland, Sweden, and the United Kingdom as well as earmarked contributions for specific projects from a variety of donors.
Uploads
Papers by Jires Tunguhole